TrialBritish journal of cancer2016

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.

Stacey M Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.